Elevated cellular immune responses and interferon-γ release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis

Erliyani Sartono, Yvonne C.M. Kruize, Agnes Kurniawan, Peter H. Van der Meide, Felix Partono, Rick M. Maizels, Maria Yazdanbakhsh

Research output: Contribution to journalArticlepeer-review

80 Citations (Scopus)

Abstract

Cellular immune responses to filarial antigens were examined in persons before and 1 year after beginning treatment with diethylcarbamazine (DEC). The subjects (17 microfilaremics, 13 asymptomatic amicrofilaremics, and 13 with elephantiasis) had not responded to Brugia malayi adult worm antigen (BmA) before chemotherapy. T cell proliferative responses to BmA improved significantly after therapy in the 3 clinical groups (P <.05) but was highest in the elephantiasis patients and asymptomatic amicrofilaremics. Cytokine release profiles after stimulation with parasite antigen were analyzed. Production ofinterferon (IFN)-γ by BmA-stimulated mononuclear cells increased significantly after DEC treatment (geometric mean, 39.6-55.7 U/mL; P <.05), largely due to improved responses in elephantiasis patients and asymptomatic amicrofilaremics. In contrast, BmA-induced interleukin (IL)-4 release did not change significantly in these same patients after treatment. Thus, both microfilaremic and amicrofilaremic infections with B. malayi are associated with similar down-regulation of proliferative T cell function and IFN-γ release.

Original languageEnglish
Pages (from-to)1683-1687
Number of pages5
JournalJournal of Infectious Diseases
Volume171
Issue number6
DOIs
Publication statusPublished - Jun 1995

Fingerprint

Dive into the research topics of 'Elevated cellular immune responses and interferon-γ release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis'. Together they form a unique fingerprint.

Cite this